Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | HBB | P68871 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.41 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butylamine SCHEMBL4171119 | 1.00 | APP (0.44) | APPDNM1ALDH1A1TSHRMEN1 | |
| Sulfuric Acid SCHEMBL10651801 | 0.93 | DNM1 (0.55) | APPDNM1ALDH1A1TSHRMEN1 | |
| Butylamine SCHEMBL28262917 | 0.93 | TSHR (0.46) | APPDNM1ALDH1A1TSHRMEN1 | |
| Butylamine SCHEMBL28148801 | 0.93 | TSHR (0.46) | APPDNM1ALDH1A1TSHRMEN1 | |
| Sulfuric Acid SCHEMBL8299431 | 0.91 | DNM1 (0.59) | DNM1ALDH1A1TSHRMEN1KMT2A | |
| Pentadecylamine SCHEMBL9540009 | 0.91 | DNM1 (0.59) | DNM1ALDH1A1TSHRMEN1KMT2A | |
| Sulfuric Acid SCHEMBL10450188 | 0.87 | — | — | |
| Butylamine SCHEMBL21981130 | 0.87 | DNM1 (0.50) | APPDNM1ALDH1A1TSHRMEN1 | |
| Butylamine SCHEMBL288211 | 0.87 | DNM1 (0.50) | APPDNM1ALDH1A1TSHRMEN1 | |
| Butylamine SCHEMBL537120 | 0.87 | DNM1 (0.50) | APPDNM1ALDH1A1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024201231-A1 | A PROCESS FOR THE PREPARATION OF ISOXAZOLINE-SUBSTITUTED AMIDE COMPOUNDS AND ITS INTERMEDIATES THEREOF | HIKAL LIMITED (IN) | 2024-10-03 | — | — | WO | claimed |
| EP-4294977-A1 | DYE RECYCLING METHODS | Imperial College Innovations Limited (GB) | 2023-12-27 | — | — | EP | claimed |
| EP-3752496-A1 | METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION | GILEAD SCIENCES, INC. (US) | 2020-12-23 | — | — | EP | claimed |
| WO-2019161280-A1 | METHODS AND INTERMEDIATES FOR PREPARING A THERAPEUTIC COMPOUND USEFUL IN THE TREATMENT OF RETROVIRIDAE VIRAL INFECTION | GILEAD SCIENCES, INC. (US) | 2019-08-22 | — | — | WO | claimed |
| EP-2951140-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,3,3-TRIFLUOROPROPENE USING A PHASE TRANSFER CATALYST | Honeywell International Inc. (US) | 2015-12-09 | — | — | EP | claimed |
| WO-2014121171-A1 | PROCESS FOR THE PREPARATION OF 1-CHLORO-3,3,3-TRIFLUOROPROPENE USING A PHASE TRANSFER CATALYST | HONEYWELL INTERNATIONAL INC. (US) | 2014-08-07 | — | — | WO | claimed |
| EP-1287145-A2 | THE NON-MEVALONATE ISOPRENOID PATHWAY | Bacher, Adelbert (DE) | 2003-03-05 | — | — | EP | claimed |
| WO-2001094561-A2 | THE NON-MEVALONATE ISOPRENOID PATHWAY | BACHER ADELBERT (DE) | 2001-12-13 | — | — | WO | claimed |
| EP-0358856-A2 | Novel insecticidal dibenzoyl-tert-butylcarbanonitrile compounds and method for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1990-03-21 | — | — | EP | claimed |
| EP-4045001-B1 | AN ANTIPERSPIRANT COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2025-09-24 | — | — | EP | disclosed |
| US-20250110101-A1 | PER AND POLYFLUOROALKYL SUBSTANCE MEASUREMENT | DEXSIL CORPORATION (US) | 2025-04-03 | — | — | US | disclosed |
| US-20240358621-A1 | PERSONAL CARE COMPOSITION | CONOPCO, INC., D/B/A UNILEVER | 2024-10-31 | — | — | US | disclosed |
| EP-4044991-B1 | ANTIPERSPIRANT EMULSION | UNILEVER IP HOLDINGS B V (NL) | 2024-10-02 | — | — | EP | disclosed |
| WO-2024104964-A1 | NEW METHOD FOR RECYCLING OF POLYISOCYANURATES | EVONIK OPERATIONS GMBH (DE) | 2024-05-23 | — | — | WO | disclosed |
| US-4203973-A | AMOXYCILLIN AND ANTIBIOTIC MM455OA | BEECHAM GROUP LIMITED (GB) | 1980-05-20 | — | — | US | disclosed |
| US-4189473-A | Antibiotic MM 13902 | BEECHAM GROUP LIMITED (GB) | 1980-02-19 | — | — | US | disclosed |
| US-4181716-A | PURIFICATION OF ANITBIOTIC MM 455OA BY CHROMATOGRAPHY ON CELLULOSE | BEECHAM GROUP LIMITED (GB) | 1980-01-01 | — | — | US | disclosed |
| US-4172129-A | ANTIBIOTIC MM4553A; BETA-LACTAMASE INHIBITOR | BEECHAM GROUP LIMITED (GB) | 1979-10-23 | — | — | US | disclosed |
| US-4146610-A | ANTIBIOTICS MM13902 | BEECHAM GROUP LIMITED (GB) | 1979-03-27 | — | — | US | disclosed |
| US-4113856-A | OBTAINED BY FERMENTATION, SYNERGISM | BEECHAM GROUP LIMITED (GB) | 1978-09-12 | — | — | US | disclosed |